Back to
JARISLOWSKY, FRASER Ltd
ABT28 quarters
Position history for
JARISLOWSKY, FRASER Ltd's holdings in ABBOTT LABORATORIES
As of its last 13F, for Q3 2025, Jarislowsky, Fraser held 2,158,089 shares of ABT (Abbott Laboratories), worth $289.1M. It reduced the position by 37,740 shares (-1.7%) from Q2 2025. Jarislowsky, Fraser held ABT from Q4 2018 to Q3 2025, across 28 quarterly 13F filings. ABT was 1.6% of Jarislowsky, Fraser's reported 13F portfolio.
Current Value
$289.1M
Current Shares
2.2M
Total Value Change
+$126.4M
Total Shares Change
-90,413
Quarter-by-Quarter History
Other major holders of ABT: VANGUARD GROUP INC, BlackRock, Inc.